JONATHAN WEATHERLY: Open Payments
NPI 1104698745 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$668 in 16 payments from 13 companies in 2025. Trend: 2023 $22 · 2024 $1,040 · 2025 $668
Food & beverage: $668
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 1 | $133 |
| Novocure Inc. | 1 | $129 |
| Astellas Pharma US Inc | 1 | $103 |
| Novartis Pharmaceuticals Corporation | 3 | $74 |
| Incyte Corporation | 2 | $51 |
| Exelixis Inc. | 1 | $28 |
| EMD Serono, Inc. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| TerSera Therapeutics LLC | 1 | $24 |
| Lilly USA, LLC | 1 | $22 |
Products named: ZIIHERA, Optune Lua (NovoTTF-200T), Vyloy, Fabhalta, KISQALI, CABOMETYX, JAKAFI, MONJUVI.
Industry payments across TN — which companies pay providers there.
